BRCA1 and endometrioid tumor: BRCA1/2 mutations were more commonly identified in serous epithelial cancers and a non‐endometrioid tumor, while patients with a mutation in genes other than BRCA mutations were seen in neither serous nor endometrioid tumor (p value = .001, p value = .007, respectively) (Table 1).